UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):
FEBRUARY 26, 2004
KOSAN BIOSCIENCES INCORPORATED
(Exact name of registrant specified in its charter)
| | | | |
| DELAWARE | | 000-31633 | | 94-3217016 |
(State or other jurisdiction of incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
3832 BAY CENTER PLACE HAYWARD, CA 94545
(Address of principal executive offices) (Zip Code)
REGISTRANT’S TELEPHONE, INCLUDING AREA CODE: (510) 732-8400
Item 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On February 26, 2004, Kosan Biosciences Incorporated (the “Company”) announced via a press release its financial results for the three and twelve months ended December 31, 2003. A copy of the Company’s press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The information in this Report on Form 8-K, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | |
KOSAN BIOSCIENCES INCORPORATED |
(Registrant) |
| |
By | | /s/ Daniel V. Santi, M.D., Ph.D.
|
| | | Daniel V. Santi, M.D., Ph.D. |
| | | Chairman and Chief Executive Officer |
Dated: February 26, 2004
EXHIBIT INDEX
| | |
Exhibit
| | Description
|
| 99.1 | | Press Release dated February 26, 2004, relating to the Company’s financial results for the three and twelve months ended December 31, 2003. |
